Aprotinin reduces vasoactive medication use during adult liver transplantation

Journal of Clinical Anesthesia

Volumn 15, Issue 1, 2003, Pages 19-23

  Findlay, James Y ^a   Kufner, Ronald P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aprotinin; Hemodynamics; Liver transplantation

Indexed keywords

ADRENALIN; APROTININ; CALCIUM CHLORIDE; DOBUTAMINE; DOPAMINE; FENTANYL; HYPERTENSIVE AGENT; ISOFLURANE; PHENYLEPHRINE; SODIUM CHLORIDE; SUXAMETHONIUM; THIOPENTAL; VASOACTIVE AGENT;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLEEDING; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INFUSION; DRUG USE; ENDOTRACHEAL INTUBATION; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; HYPOTENSION; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; OPERATION DURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; STATISTICAL SIGNIFICANCE; SYSTEMIC VASCULAR RESISTANCE;

EID: 0037300068     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(02)00475-0     Document Type: Article

References (20)

1. Garcia L., Sabate A., Domenech P., Martinez-Brotons F., Drudis R., Jaurrieta E. Aprotinin in OLT. Transplant Proceed. 27:1995;2290-2291.
2. Garcia-Huete L., Domenech P., Sabate A., Martinez-Brotons F., Juarrieta E., Figueras J. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation a randomized clinical study . Hepatology. 26:1997;1143-1148.
3. Kufner R.P. Antifibrinolytics do not reduce transfusion requirements in patients undergoing OLT. Liver Transpl Surg. 3:1997;668-674.
4. Bechstein W.O., Riess H., Blumhardt G., et al. Aprotinin in OLT. Semin Thromb Hemost. 19:1993;262-267.
5. Mallett S., Rolles K., Cox D., Burroughs A., Hunt B. Intraoperative use of aprotinin (Trasylol) in OLT. Transplant Proceed. 23:1991;1931-1932.
6. Smith O., Hazlehurst G., Brozovic B., et al. Impact of aprotinin on blood transfusion requirements in liver transplantation. Transfus Med. 3:1993;97-102.
7. Findlay JY, Rettke SR, Ereth MH, Plevak DJ, Krom RAF, Kufner RP: Aprotinin reduces red blood cell transfusion in OLT. a prospective, randomized, double-blind study. Liver Transpl: 802-807.
8. Porte R.J., Molenaar I.Q., Begliomini B., et al. Aprotinin and transfusion requirements in OLT a multicentre randomised double-blind study. EMSALT Study Group . Lancet. 355:2000;1303-1309.
9. Segal H., Hunt B.J. Aprotinin pharmacological reduction of perioperative bleeding . Lancet. 355:2000;1289-1290.
10. Royston D. Preventing the inflammatory response to open-heart surgery the role of aprotinin and other protease inhibitors . Int J Cardiol. 53:1996;S11-37.
11. Cumming A.D. Acute renal failure and sepsis therapeutic approaches . Nephrol Dial Transpl. 9:1994;159-163.
12. MacGilchrist A., Craig K.J., Hayes P.C., Cumming A.D. Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites. Clin Sci (Lond). 87:1994;329-335.
13. Wan S., LeClerc J., Vincent J.L. Inflammatory response to cardiopulmonary bypass mechanisms involved and possible therapeutic strategies . Chest. 112:1997;676-692.
14. Milroy S.J., Cottam S., Tan K.C., Hilmi I., Oyesola B. Improved haemodynamic stability with administration of aprotinin during OLT. Br J Anaesth. 75:1995;747-751.
15. Molenaar I.Q., Begliomini B., Martinelli G., Putter H., Terpstra O.T., Porte R.J. Reduced need for vasopressors in patients receiving aprotinin during OLT. Anesthesiology. 94:2001;433-438.
16. Kang Y.G., Freeman J.A., Aggarwal S., De Wolf A.M. Hemodynamic instability during liver transplantation. Transpl Proc. 21:1989;3489-3492.
17. Rettke S.R., Janossy T.A., Chantigian R.C., et al. Hemodynamic and metabolic changes in hepatic transplantation. Mayo Clin Proc. 64:1989;232-240.
18. Cottam S., Milroy S.J. Aprotinin during liver transplantation (letter). Br J Anaesth. 75:1995;882.
19. Peters D.C., Noble S. Aprotinin an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery . Drugs. 57:1999;233-260.
20. Dobkowski W.B., Grant D.R., Wall W.J. Additional dose of aprotinin may improve hemodynamics during postreperfusion period in patients undergoing OLT. Anesth Analg. 86:1998;S123.